Page 2 - Eric Borin News Today

Designed for reliability and efficiency, Effivax supports the rapid growth and stringent needs of vaccine manufacturing.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a next-generation glass...

BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug DeliveryFRANKLIN LAKES, N.J., October 13, 2021 / B3C newswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD SCF™ PremiumCoat®&dagger...

New BD plant set for Spain aims to meet growing demand for PFS Becton, Dickinson and Company (BD) is to build a new plant in Zaragoza, Spain, with an investment of €165m (US$200m). The site will produce glass pre-filled syringes and plastic components. “BDs new plant in Zaragoza will produce drug delivery devices, primarily for pharmaceutical companies that supply the European market with drugs in PFS such as vaccines and other biologics,”​ said Eric Borin, w...

Becton Dickinson and Co (NYSE: BDX) will build a €165 million ($200 million) high-tech manufacturing facility in Zaragoza, Spain, that will create up to 600 jobs by 2030. BD plans to begin constructing the new plant in late 2021, and the new facility will be the fourth manufacturing plant for BD in Spain. The site will initially have a 150 workforce and encompass 8,000 square meters (86,000 square feet). "BD's new plant in Zaragoza will produce drug delivery devices, primarily f...

BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain To Support Ongoing Strong Growth of Pre-Filled Drug Delivery BusinessNew plant will produce drug delivery devices, employ 150 people in 2024 and up to 600 when full operations start in 2030MADRID, Spain, May 18, 2021 / B3C newswire / -- BD (...

BD Building $202M Manufacturing Facility In Spain By Law360 is providing free access to its coronavirus coverage to make sure all members of the legal community have accurate information in this time of uncertainty and change. Use the form below to sign up for any of our weekly newsletters. Signing up for any of our section newsletters will opt you in to the weekly Coronavirus briefing. Sign up for our Construction newsletter You must correct or enter the following before you can sign ...

Investment includes new manufacturing facility in Europe. This content was submitted directly to this website by the supplier. Dec 14th, 2020 BD (Becton, Dickinson and Company), a global medical technology company, announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) across its six global manufacturing locations and add a new manufacturing fa...

New Clinical Trial Data Demonstrates BD Libertas Wearable Injector As A Drug Delivery System BD (Becton, Dickinson and Company), a leading global medical technology company, today announced publication of the results from a 52-subject human clinical trial with the BD Libertas Wearable Injector. The subcutaneous drug delivery system, currently in final phases of development, is designed as ready to use and to deliver drugs such as biologics with viscosities up to 50 cP in 2-5 mL and 5-10 mL con...